CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,437 |
| 2024-08-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $46.24 | $809K | 220,937 |
| 2024-08-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 105,000 | ||
| 2024-08-14 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,437 |
| 2024-08-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $45.17 | $790K | 220,937 |
| 2024-08-14 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 122,500 | ||
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +5,000 | $3.74 | $19K | 16,900 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −5,000 | $45.92 | $230K | 11,900 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +2,000 | $3.74 | $7K | 13,900 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −2,000 | $45.99 | $92K | 11,900 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +5,000 | 0 | ||
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +2,000 | 13,000 | ||
| 2024-07-18 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,437 |
| 2024-07-18 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $51.40 | $900K | 220,937 |
| 2024-07-18 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 140,000 | ||
| 2024-07-17 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,437 |
| 2024-07-17 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $51.55 | $902K | 220,937 |
| 2024-07-17 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 157,500 | ||
| 2024-07-16 | Flynn Sean C. Chief Legal Officer | Option exercise 10b5-1 | +15,000 | $16.25 | $244K | 15,707 |
| 2024-07-16 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $52.18 | $783K | 707 |
Page 24 of 75 · 1,497 trades